SEARCH

SEARCH BY CITATION

References

  • Alazard, R., Blaud, M., Elbaz, S., Vossen, C., Icre, G., Joseph, G., Nieto, L., and Erard, M. (2005). Identification of the ‘NORE’ (N-Oct-3 responsive element), a novel structural motif and composite element. Nucleic Acids Res. 33, 15131523.
  • Cabos-Siguier, B., Steunou, A.L., Joseph, G., Alazard, R., Ducoux-Petit, M., Nieto, L., Monsarrat, B., Erard, M., and Clottes, E. (2009). Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth. Protein Expr. Purif. 64, 3946.
  • Castro, D.S., Skowronska-Krawczyk, D., Armant, O. et al. (2006). Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Dev. Cell 11, 831844.
  • Chambers, I., and Tomlinson, S.R. (2009). The transcriptional foundation of pluripotency. Development 136, 23112322.
  • Chen, X., Vega, V.B., and Ng, H.H. (2008). Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb. Symp. Quant. Biol. 73, 203209.
  • Chen, K.G., Valencia, J.C., Gillet, J.P., Hearing, V.J., and Gottesman, M.M. (2009). Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res. 22, 740749.
  • Cook, A.L., and Sturm, R.A. (2008). POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis. Pigment Cell Melanoma Res. 21, 611626.
  • Cook, A.L., Donatien, P.D., Smith, A.G., Murphy, M., Jones, M.K., Herlyn, M., Bennett, D.C., Leonard, J.H., and Sturm, R.A. (2003). Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. J. Invest. Dermatol. 121, 11501159.
  • Davidson, I., Xiao, J.H., Rosales, R., Staub, A., and Chambon, P. (1988). The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54, 931942.
  • Delacroix, L., Moutier, E., Altobelli, G., Legras, S., Poch, O., Choukrallah, M.A., Bertin, I., Jost, B., and Davidson, I. (2010). Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol. Cell. Biol. 30, 231244.
  • Delmas, V., Beermann, F., Martinozzi, S. et al. (2007). Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21, 29232935.
  • Eisen, T., Easty, D.J., Bennett, D.C., and Goding, C.R. (1995). The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 11, 21572164.
  • Fadloun, A., Kobi, D., Delacroix, L., Dembele, D., Michel, I., Lardenois, A., Tisserand, J., Losson, R., Mengus, G., and Davidson, I. (2008). Retinoic acid induces TGFb-dependent autocrine fibroblast growth. Oncogene 27, 477489.
  • Fujii, H., and Hamada, H. (1993). A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 11, 11971206.
  • Garrido, M.C., and Bastian, B.C. (2009). KIT as a therapeutic target in melanoma. J. Invest. Dermatol. 130, 2027.
  • Goodall, J., Martinozzi, S., Dexter, T.J., Champeval, D., Carreira, S., Larue, L., and Goding, C.R. (2004a). Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol. Cell. Biol. 24, 29152922.
  • Goodall, J., Wellbrock, C., Dexter, T.J., Roberts, K., Marais, R., and Goding, C.R. (2004b). The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol. Cell. Biol. 24, 29232931.
  • Goodall, J., Carreira, S., Denat, L., Kobi, D., Davidson, I., Nuciforo, P., Sturm, R.A., Larue, L., and Goding, C.R. (2008). Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 68, 77887794.
  • Huang, S., Luca, M., Gutman, M., Mcconkey, D.J., Langley, K.E., Lyman, S.D., and Bar-Eli, M. (1996). Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 13, 23392347.
  • Huang, S., Jean, D., Luca, M., Tainsky, M.A., and Bar-Eli, M. (1998). Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J. 17, 43584369.
  • Isenberg, J.S., Martin-Manso, G., Maxhimer, J.B., and Roberts, D.D. (2009). Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat. Rev. Cancer 9, 182194.
  • Klemm, J.D., and Pabo, C.O. (1996). Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage. Genes Dev. 10, 2736.
  • Klemm, J.D., Rould, M.A., Aurora, R., Herr, W., and Pabo, C.O. (1994). Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77, 2132.
  • Labella, F., Sive, H.L., Roeder, R.G., and Heintz, N. (1988). Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev. 2, 3239.
  • Larue, L., and Delmas, V. (2009). Secrets to developing Wnt-age melanoma revealed. Pigment Cell Melanoma Res. 22, 520521.
  • Latchman, D.S. (1996). The Oct-2 transcription factor. Int. J. Biochem. Cell Biol. 28, 10811083.
  • Le Douarin, N.M., Calloni, G.W., and Dupin, E. (2008). The stem cells of the neural crest. Cell Cycle 7, 10131019.
  • Lefort, K., Rouault, J.P., Tondereau, L., Magaud, J.P., and Dore, J.F. (2001). The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Oncogene 20, 73757385.
  • Li, P., He, X., Gerrero, M.R., Mok, M., Aggarwal, A., and Rosenfeld, M.G. (1993). Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7, 24832496.
  • Lincke, C.R., Van Der Bliek, A.M., Schuurhuis, G.J., Van Der Velde-Koerts, T., Smit, J.J., and Borst, P. (1990). Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res. 50, 17791785.
  • Mcgill, G.G., Haq, R., Nishimura, E.K., and Fisher, D.E. (2006). c-Met expression is regulated by Mitf in the melanocyte lineage. J. Biol. Chem. 281, 1036510373.
  • Mengus, G., Fadloun, A., Kobi, D., Thibault, C., Perletti, L., Michel, I., and Davidson, I. (2005). TAF4 inactivation in embryonic fibroblasts activates TGFbeta signalling and autocrine growth. EMBO J. 24, 27532767.
  • Moore, R., Champeval, D., Denat, L., Tan, S.S., Faure, F., Julien-Grille, S., and Larue, L. (2004). Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 23, 67266735.
  • Nakai, S., Kawano, H., Yudate, T. et al. (1995). The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9, 31093121.
  • Nieto, L., Joseph, G., Stella, A., Henri, P., Burlet-Schiltz, O., Monsarrat, B., Clottes, E., and Erard, M. (2007). Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures. J. Mol. Biol. 370, 687700.
  • Phillips, K., and Luisi, B. (2000). The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302, 10231039.
  • Pinner, S., Jordan, P., Sharrock, K., Bazley, L., Collinson, L., Marais, R., Bonvin, E., Goding, C., and Sahai, E. (2009). Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69, 79697977.
  • Pruitt, S.C., Bussman, A., Maslov, A.Y., Natoli, T.A., and Heinaman, R. (2004). Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo. Gene Expr. Patterns 4, 671685.
  • Qian, F., Vaux, D.L., and Weissman, I.L. (1994). Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77, 335347.
  • Remenyi, A., Tomilin, A., Pohl, E., Lins, K., Philippsen, A., Reinbold, R., Scholer, H.R., and Wilmanns, M. (2001). Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 8, 569580.
  • Rosales, R., Vigneron, M., Macchi, M., Davidson, I., Xiao, J.H., and Chambon, P. (1987). In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers. EMBO J. 6, 30153025.
  • Ryan, A.K., and Rosenfeld, M.G. (1997). POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 11, 12071225.
  • Salinas, P.C., and Zou, Y. (2008). Wnt signaling in neural circuit assembly. Annu. Rev. Neurosci. 31, 339358.
  • Schatton, T., Murphy, G.F., Frank, N.Y. et al. (2008). Identification of cells initiating human melanomas. Nature 451, 345349.
  • Schonemann, M.D., Ryan, A.K., Mcevilly, R.J., O’connell, S.M., Arias, C.A., Kalla, K.A., Li, P., Sawchenko, P.E., and Rosenfeld, M.G. (1995). Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9, 31223135.
  • Schonemann, M.D., Ryan, A.K., Erkman, L., Mcevilly, R.J., Bermingham, J., and Rosenfeld, M.G. (1998). POU domain factors in neural development. Adv. Exp. Med. Biol. 449, 3953.
  • Sid, B., Sartelet, H., Bellon, G., El Btaouri, H., Rath, G., Delorme, N., Haye, B., and Martiny, L. (2004). Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Crit. Rev. Oncol. Hematol. 49, 245258.
  • Silverstein, R.L., and Febbraio, M. (2007). CD36-TSP-HRGP interactions in the regulation of angiogenesis. Curr. Pharm. Des. 13, 35593567.
  • Silverstein, R.L., and Febbraio, M. (2009). CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2, re3.
  • Smit, D.J., Smith, A.G., Parsons, P.G., Muscat, G.E., and Sturm, R.A. (2000). Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 267, 64136422.
  • Sugitani, Y., Nakai, S., Minowa, O., Nishi, M., Jishage, K., Kawano, H., Mori, K., Ogawa, M., and Noda, T. (2002). Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. Genes Dev. 16, 17601765.
  • Thomson, J.A., Murphy, K., Baker, E., Sutherland, G.R., Parsons, P.G., Sturm, R.A., and Thomson, F. (1995). The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 11, 691700.
  • Tomilin, A., Remenyi, A., Lins, K., Bak, H., Leidel, S., Vriend, G., Wilmanns, M., and Scholer, H.R. (2000). Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell 103, 853864.
  • Wehrle-Haller, B. (2003). The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res. 16, 287296.
  • Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T., and Marais, R. (2008). Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE 3, e2734.
  • Wu, M., Hemesath, T.J., Takemoto, C.M., Horstmann, M.A., Wells, A.G., Price, E.R., Fisher, D.Z., and Fisher, D.E. (2000). c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301312.
  • Zakut, R., Perlis, R., Eliyahu, S., Yarden, Y., Givol, D., Lyman, S.D., and Halaban, R. (1993). KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 8, 22212229.